29 April 2022
BDA China Growth Capital Conference 2022
BDA Partners hosted our inaugural China Growth Capital Conference on April 26th – 28th. 20 presenting companies from consumer, health, services and technology sectors gave presentations to growth capital investors in over 200 virtual one-on-one meetings.
Anthony Siu, Partner and Co-Head of Shanghai, said: “Our 3-day virtual conference was a big success. It was BDA’s first growth capital conference and it attracted over 300 investors from 150 PE firms to participate in our conference. The attendees included blue-chip global and China USD funds as well as China RMB funds. We also received strong support from Founders and CEOs of high-growth companies in China to present at our conference. These companies represent industries which are at the forefront of China’s economic development including digital health, in-vitro diagnostics, premium healthcare services, lifestyle & wellness and fintech. The strong turnout reflects investor appetite for high-quality companies set to benefit from China’s rapid transformation toward an advanced economy. It also demonstrates ample private market liquidity seeking mid to late stage opportunities in China. We are very pleased to be the partner of choice for our clients in bringing private capital and exciting growth opportunities together.”
We look forward to our next BDA China Growth Capital Conference in 2023, and also the annual BDA PE Conference in late 2022. Please contact us at gcc@bdapartners.com or pe-conference@bdapartners.com if you would like to learn more about either conference, and the benefits of both presenting and attending.

Latest insights
19 April 2022
Advising clients in Hong Kong since 2000
Since 2020 BDA has successfully advised on nearly 60 transactions, making...
13 April 2022
Opportunities abound: 25 years of M&A in Vietnam
The article was originally published on April 2022 issue of Vietnam Economic...
6 April 2022
Unlocking value with strategic corporate divestments in China
In recent years, moderating GDP growth, fierce competition from local players,...
25 January 2022
2022 – the year ahead in Healthcare
2021 was a phenomenal year for deal activity in the Healthcare sector....